NO307644B1 - Transdermalt, terapeutisk system med krystalliseringsinhibitor - Google Patents

Transdermalt, terapeutisk system med krystalliseringsinhibitor

Info

Publication number
NO307644B1
NO307644B1 NO941593A NO941593A NO307644B1 NO 307644 B1 NO307644 B1 NO 307644B1 NO 941593 A NO941593 A NO 941593A NO 941593 A NO941593 A NO 941593A NO 307644 B1 NO307644 B1 NO 307644B1
Authority
NO
Norway
Prior art keywords
therapeutic system
transdermal therapeutic
crystallization inhibitor
crystallization
inhibitor
Prior art date
Application number
NO941593A
Other languages
English (en)
Norwegian (no)
Other versions
NO941593L (no
NO941593D0 (fi
Inventor
Ralph Lipp
Jutta Riedl
Johannes-Wilhelm Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO941593L publication Critical patent/NO941593L/no
Publication of NO941593D0 publication Critical patent/NO941593D0/no
Publication of NO307644B1 publication Critical patent/NO307644B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO941593A 1991-10-31 1994-04-29 Transdermalt, terapeutisk system med krystalliseringsinhibitor NO307644B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren
PCT/EP1992/002478 WO1993008795A1 (de) 1991-10-31 1992-10-21 Transdermale therapeutische systeme mit kristallisationsinhibitoren

Publications (3)

Publication Number Publication Date
NO941593L NO941593L (no) 1994-04-29
NO941593D0 NO941593D0 (fi) 1994-04-29
NO307644B1 true NO307644B1 (no) 2000-05-08

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941593A NO307644B1 (no) 1991-10-31 1994-04-29 Transdermalt, terapeutisk system med krystalliseringsinhibitor

Country Status (14)

Country Link
EP (1) EP0610357B1 (fi)
JP (1) JP3526864B2 (fi)
AT (1) ATE158181T1 (fi)
AU (2) AU2895392A (fi)
CA (1) CA2120599C (fi)
DE (2) DE4210711A1 (fi)
DK (1) DK0610357T3 (fi)
ES (1) ES2106888T3 (fi)
FI (1) FI110061B (fi)
GR (1) GR3025237T3 (fi)
HU (1) HU227531B1 (fi)
NO (1) NO307644B1 (fi)
PT (1) PT101019B (fi)
WO (1) WO1993008795A1 (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
AU7396294A (en) 1993-06-25 1995-01-24 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
CN1188189C (zh) † 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
EP1857103B1 (en) 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
WO2009107476A1 (ja) 2008-02-27 2009-09-03 久光製薬株式会社 貼付製剤
ES2661767T3 (es) 2008-02-27 2018-04-03 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo para la piel y producto envasado
US20110189261A1 (en) 2008-03-03 2011-08-04 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
EP3045166B1 (en) * 2013-09-11 2020-12-16 MEDRx Co., Ltd. Novel base composition for tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
AU2895392A (en) 1993-06-07
JP3526864B2 (ja) 2004-05-17
NO941593L (no) 1994-04-29
AU712692B2 (en) 1999-11-11
FI942011A (fi) 1994-04-29
DE59208918D1 (de) 1997-10-23
WO1993008795A1 (de) 1993-05-13
FI942011A0 (fi) 1994-04-29
PT101019A (pt) 1994-02-28
JPH07506083A (ja) 1995-07-06
ES2106888T3 (es) 1997-11-16
HU227531B1 (en) 2011-07-28
NO941593D0 (fi) 1994-04-29
PT101019B (pt) 1999-10-29
DE4210711A1 (de) 1993-05-06
CA2120599C (en) 2003-04-15
HU9401257D0 (en) 1994-08-29
EP0610357A1 (de) 1994-08-17
AU1652997A (en) 1997-05-29
GR3025237T3 (en) 1998-02-27
DK0610357T3 (da) 1998-05-11
CA2120599A1 (en) 1993-05-13
EP0610357B1 (de) 1997-09-17
FI110061B (fi) 2002-11-29
ATE158181T1 (de) 1997-10-15
HUT72964A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
NO307644B1 (no) Transdermalt, terapeutisk system med krystalliseringsinhibitor
DK0596903T3 (da) Transdermale, terapeutiske systemer.
MY109727A (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
DE69426988D1 (de) Transdermale abgabe vorrichtung
DE68915413D1 (de) Anzeigevorrichtung mit aktiver Matrix.
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
DE68924247D1 (de) Anzeigevorrichtung mit aktiver Matrix.
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
DE3585905D1 (de) Aktives matrixanzeigegeraet.
AR009516A1 (es) Un dispositivo de parche de matriz adhesiva sensible a la presion, un metodo para preparar dicho dispositivo y un metodo para emplear dichodispositivo en el suministro transdermico de una droga.
DK0794770T3 (da) Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning
FI950165A (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena on 17-beta-estradioli (vedetön)
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
ATE289818T1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination
KR900011031A (ko) 액티브 매트릭스 패널용 박막트랜지터
KR900011032A (ko) 액티브 매트릭스 패널용 박막트랜지터

Legal Events

Date Code Title Description
MK1K Patent expired